China Pharma & Biotech: ASCO 2026 Part 3 - Summary (for when fundamentals begin to matter again)制药/制药装备医疗/医药Bernstein2026-06-0325 页
Global Healthcare: The Obesity Evolution: Framing global AOM peptide manufacturing capacity and implications for the branded/generic markets制药/制药装备医疗/医药Goldman Sachs2026-06-0545 页